Article

INVESTIGATING THE MOLECULAR GENETICS OF ADVERSE DRUG REACTIONS

2026-08-26

Abstract excerpt

Inter-individual variability in drug response remains a major challenge for contemporary medicine and is a leading contributor to adverse drug reactions (ADRs), which impose a substantial burden on patients and healthcare systems worldwide. While clinical, demographic, and treatment-related factors are recognised determinants of ADR risk, inherited genetic variation represents an important but incompletely charact...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: aab6906a-8512-5690-b189-477a797262d4
DOI: 10.17638/03199005

Open publication

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Click a neighbor to travelStep 1 · 12 closest

INVESTIGATING THE MOLECULAR GENETICS OF ADVERSE DRUG REACTIONSDOI 10.17638/03199005Read

Genophenotypic Factors and Pharmacogenomics in Adverse Drug Reactions.Semantic proximity Read

Pharmacogenetics of Adverse Drug Reactions.Semantic proximity Read

Genomics of Adverse Drug Reactions.Semantic proximity Read

Digging up the human genome: current progress in deciphering adverse drug reactions.Semantic proximity Read

Genomic Risk Factors Driving Immune-Mediated Delayed Drug Hypersensitivity ReactionsSemantic proximity Read

Personalized medicine: Genetic risk prediction of drug response.Semantic proximity Read

Progress in understanding the genomic basis for adverse drug reactions: a comprehensive review and focus on the role of ethnicity.Semantic proximity Read

Drug-Induced Skin Adverse Reactions: The Role of Pharmacogenomics in Their Prevention.Semantic proximity Read

The role of pharmacogenomics in adverse drug reactionsSemantic proximity Read

Severe Cutaneous Adverse Reactions: The Pharmacogenomics from Research to Clinical ImplementationSemantic proximity Read

A genomic-led strategy to anticipate drug safety effectsSemantic proximity Read

Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges.Semantic proximity Read